Morgan Stanley
NRXS icon

Morgan Stanley’s Neuraxis NRXS Stock Holding History

Morgan Stanley’s Portfolio NRXS Stock Details NRXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.4K Hold
5,802
– – ﹤0.01% 6569
2026
Q1 		$42.9K Hold
5,802
– – ﹤0.01% 6476
2025
Q4 		$26.3K Hold
5,802
– – ﹤0.01% 6607
2025
Q3 		$17.9K Hold
5,802
– – ﹤0.01% 6720
2025
Q2 		$14K Buy
+5,802
New +$13.6K ﹤0.01% 6769

Other funds holding NRXS

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCC
Money Concepts Capital Palm Beach Gardens, Florida $2.16B AUM 28.67% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
PC
Panoramic Capital Larkspur, California $232M AUM 255.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Morgan Stanley's NRXS Position: Q2 2026 in Review

Morgan Stanley held its Neuraxis (NRXS) position steady in Q2 2026 at 5,802 shares worth $42.4K. The position accounts for ﹤0.01% of the portfolio, ranked #6569.

Morgan Stanley first reported a position in NRXS in Q2 2025 and has held it in 5 quarters since. The position peaked at $42.9K in Q1 2026. 32 funds tracked by Wall St. Rank hold NRXS as of Q2 2026.

  • Morgan Stanley held 5,802 shares of Neuraxis worth $42.4K as of Q2 2026.
  • Morgan Stanley left its Neuraxis share count unchanged in Q2 2026.
  • Neuraxis made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6569 holding.
  • Morgan Stanley first reported a position in Neuraxis in Q2 2025 and has held it in 5 quarters since.
  • Morgan Stanley's Neuraxis position peaked at $42.9K in Q1 2026.
  • 32 funds tracked by Wall St. Rank held Neuraxis as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.